Propofol and isoflurane enhancement of tonic gamma-aminobutyric acid type a current in cardiac vagal neurons in the nucleus ambiguus

Anesthesia and Analgesia

Volumn 108, Issue 1, 2009, Pages 142-148

  Wang, Xin ^a  

^a GEORGE WASHINGTON UNIVERSITY SCHOOL OF MEDICINE AND HEALTH SCIENCES   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

3 AMINO 2 (3 CARBOXYPROPYL) 6 (4 METHOXYPHENYL)PYRIDAZINIUM BROMIDE; 4 AMINOBUTYRIC ACID A RECEPTOR; FLUORESCENT DYE; ISOFLURANE; PICROTOXIN; PROPOFOL; 4 AMINOBUTYRIC ACID RECEPTOR BLOCKING AGENT; INHALATION ANESTHETIC AGENT; INTRAVENOUS ANESTHETIC AGENT;

AMBIGUUS NUCLEUS; ANIMAL CELL; ANIMAL EXPERIMENT; ARTICLE; COMPETITIVE INHIBITION; CONTROLLED STUDY; GABAERGIC TRANSMISSION; HEART MUSCLE CELL; IN VITRO STUDY; MEMBRANE CURRENT; MINIATURE ENDPLATE POTENTIAL; NEUROMODULATION; NONHUMAN; PATCH CLAMP; POSTSYNAPTIC POTENTIAL; PRIORITY JOURNAL; RAT; VAGUS NERVE; WHOLE CELL; ANIMAL; BRAIN STEM; CYTOLOGY; DOSE RESPONSE; DRUG EFFECT; HEART; INHIBITORY POSTSYNAPTIC POTENTIAL; INNERVATION; METABOLISM; MINIATURE POSTSYNAPTIC POTENTIAL; NERVE CELL INHIBITION; NEWBORN; SPRAGUE DAWLEY RAT; TIME;

ANESTHETICS, INHALATION; ANESTHETICS, INTRAVENOUS; ANIMALS; ANIMALS, NEWBORN; BRAIN STEM; DOSE-RESPONSE RELATIONSHIP, DRUG; GABA ANTAGONISTS; HEART; INHIBITORY POSTSYNAPTIC POTENTIALS; ISOFLURANE; MINIATURE POSTSYNAPTIC POTENTIALS; NEURAL INHIBITION; PROPOFOL; RATS; RATS, SPRAGUE-DAWLEY; RECEPTORS, GABA-A; TIME FACTORS; VAGUS NERVE;

EID: 58749092679     PISSN: 00032999     EISSN: None     Source Type: Journal    
DOI: 10.1213/ane.0b013e31818d8b79     Document Type: Article

References (40)

1. Farrant M, Nusser Z. Variations on an inhibitory theme: phasic and tonic activation of GABA(A) receptors. Nat Rev Neurosci 2005;6:215-29
2. Mody I. Distinguishing between GABA(A) receptors responsible for tonic and phasic conductances. Neurochem Res 2001;26:907-13
3. Mody I, De Koninck Y, Otis TS, Soltesz I. Bridging the cleft at GABA synapses in the brain. Trends Neurosci 1994;17:517-25
4. Mody I, Pearce RA. Diversity of inhibitory neurotransmission through GABA(A) receptors. Trends Neurosci 2004;27:569-75
5. McDougall SJ, Bailey TW, Mendelowitz D, Andresen MC. Propofol enhances both tonic and phasic inhibitory currents in second-order neurons of the solitary tract nucleus (NTS). Neuropharmacology 2008;54:552-63
6. Bai D, Zhu G, Pennefather P, Jackson MF, MacDonald JF, Orser BA. Distinct functional and pharmacological properties of tonic and quantal inhibitory postsynaptic currents mediated by gamma-aminobutyric acid(A) receptors in hippocampal neurons. Mol Pharmacol 2001;59:814-24
7. Bieda MC, MacIver MB. Major role for tonic GABAA conductances in anesthetic suppression of intrinsic neuronal excitability. J Neurophysiol 2004;92:1658-67
8. Feng HJ, Macdonald RL. Multiple actions of propofol on alphabetagamma and alphabetadelta GABAA receptors. Mol Pharmacol 2004;66:1517-24
9. Banks MI, Pearce RA. Dual actions of volatile anesthetics on GABA(A) IPSCs: dissociation of blocking and prolonging effects. Anesthesiology 1999;90:120-34
10. Raines DE, Claycomb RJ, Forman SA. Modulation of GABA(A) receptor function by nonhalogenated alkane anesthetics: the effects on agonist enhancement, direct activation, and inhibition. Anesth Analg 2003;96:112-8
11. Wang X, Andresen M, Mendelowitz D. Nicotinic receptors partly mediate brainstem autonomic dysfunction evoked by the inhalation anesthetic isoflurane. Anesthesiology 2007;107:A151
12. Caraiscos VB, Newell JG, You-Ten KE, Elliott EM, Rosahl TW, Wafford KA, MacDonald JF, Orser BA. Selective enhancement of tonic GABAergic inhibition in murine hippocampal neurons by low concentrations of the volatile anesthetic isoflurane. J Neurosci 2004;24:8454-8
13. Peters JH, McDougall SJ, Mendelowitz D, Koop DR, Andresen MC. Isoflurane differentially modulates inhibitory and excitatory synaptic transmission to the solitary tract nucleus. Anesthesiology 2008;108:675-83
14. Su H, Bieda MC, MacIver MB. Anesthetics discriminate between tonic and synaptic GABA-A receptors in CA1 pyramidal neurons. Anesthesiology 2006;105:A777
15. Mendelowitz D. Firing properties of identified parasympathetic cardiac neurons in nucleus ambiguus. Am J Physiol 1996;271:H2609-H2614
16. Mendelowitz D. Advances in parasympathetic control of heart rate and cardiac function. News Physiol Sci 1999;14:155-61
17. Bouairi E, Kamendi H, Wang X, Gorini C, Mendelowitz D. Multiple types of GABAA receptors mediate inhibition in brain stem parasympathetic cardiac neurons in the nucleus ambiguus. J Neurophysiol 2006;96:3266-72
18. Shafer SL. Advances in propofol pharmacokinetics and pharmacodynamics. J Clin Anesth 1993;5:14S-21S
19. Chesney MA, Perouansky M, Pearce RA. Differential uptake of volatile agents into brain tissue in vitro. Measurement and application of a diffusion model to determine concentration profiles in brain slices. Anesthesiology 2003;99:122-30
20. Franks NP, Lieb WR. Temperature dependence of the potency of volatile general anesthetics: implications for in vitro experiments. Anesthesiology 1996;84:716-20
21. Hagan CE, Pearce RA, Trudell JR, MacIver MB. Concentration measures of volatile anesthetics in the aqueous phase using calcium sensitive electrodes. J Neurosci Methods 1998;81:177-84
22. Wang X, Huang ZG, Gold A, Bouairi E, Evans C, Andresen MC, Mendelowitz D. Propofol modulates gamma-aminobutyric acidmediated inhibitory neurotransmission to cardiac vagal neurons in the nucleus ambiguus. Anesthesiology 2004;100:1198-205
23. Murugaiah KD, Hemmings HC Jr. Effects of intravenous general anesthetics on [3H]GABA release from rat cortical synaptosomes. Anesthesiology 1998;89:919-28
24. Hollrigel GS, Toth K, Soltesz I. Neuroprotection by propofol in acute mechanical injury: role of GABAergic inhibition. J Neurophysiol 1996;76:2412-22
25. Fritschy JM, Brunig I. Formation and plasticity of GABAergic synapses: physiological mechanisms and pathophysiological implications. Pharmacol Ther 2003;98:299-323
26. Haas KF, Macdonald RL. GABAA receptor subunit gamma2 and delta subtypes confer unique kinetic properties on recombinant GABAA receptor currents in mouse fibroblasts. J Physiol 1999;514(pt 1):27-45
27. Bianchi MT, Botzolakis EJ, Haas KF, Fisher JL, Macdonald RL. Microscopic kinetic determinants of macroscopic currents: insights from coupling and uncoupling of GABAA receptor desensitization and deactivation. J Physiol 2007;584:769-87
28. Lagrange AH, Botzolakis EJ, Macdonald RL. Enhanced macroscopic desensitization shapes the response of alpha4 subtypecontaining GABAA receptors to synaptic and extrasynaptic GABA. J Physiol 2007;578:655-76
29. McCartney MR, Deeb TZ, Henderson TN, Hales TG. Tonically active GABAA receptors in hippocampal pyramidal neurons exhibit constitutive GABA-independent gating. Mol Pharmacol 2007;71:539-48
30. Davies PA, Kirkness EF, Hales TG. Modulation by general anaesthetics of rat GABAA receptors comprised of alpha 1 beta 3 and beta 3 subunits expressed in human embryonic kidney 293 cells. Br J Pharmacol 1997;120:899-909
31. Zeller A, Arras M, Jurd R, Rudolph U. Mapping the contribution of beta3-containing GABAA receptors to volatile and intravenous general anesthetic actions. BMC Pharmacol 2007;7:2
32. Krasowski MD, Koltchine VV, Rick CE, Ye Q, Finn SE, Harrison NL. Propofol and other intravenous anesthetics have sites of action on the gamma-aminobutyric acid type A receptor distinct from that for isoflurane. Mol Pharmacol 1998;53:530-8
33. Caraiscos VB, Elliott EM, You-Ten KE, Cheng VY, Belelli D, Newell JG, Jackson MF, Lambert JJ, Rosahl TW, Wafford KA, MacDonald JF, Orser BA. Tonic inhibition in mouse hippocampal CA1 pyramidal neurons is mediated by alpha5 subunitcontaining gamma-aminobutyric acid type A receptors. Proc Natl Acad Sci USA 2004;101:3662-7
34. Hales TG, Lambert JJ. The actions of propofol on inhibitory amino acid receptors of bovine adrenomedullary chromaffin cells and rodent central neurones. Br J Pharmacol 1991;104:619-28
35. Hales TG, Deeb TZ, Tang H, Bollan KA, King DP, Johnson SJ, Connolly CN. An asymmetric contribution to gammaaminobutyric type A receptor function of a conserved lysine within TM2-3 of alpha1, beta2, and gamma2 subunits. J Biol Chem 2006;281:17034-43
36. Jones MV, Harrison NL. Effects of volatile anesthetics on the kinetics of inhibitory postsynaptic currents in cultured rat hippocampal neurons. J Neurophysiol 1993;70:1339-49
37. Nishikawa K, Harrison NL. The actions of sevoflurane and desflurane on the gamma-aminobutyric acid receptor type A: effects of TM2 mutations in the alpha and beta subunits. Anesthesiology 2003;99:678-84
38. Richardson JE, Garcia PS, O'Toole KK, Derry JM, Bell SV, Jenkins A. A conserved tyrosine in the beta2 subunit M4 segment is a determinant of gamma-aminobutyric acid type A receptor sensitivity to propofol. Anesthesiology 2007;107:412-8
39. Schofield CM, Harrison NL. Transmembrane residues define the action of isoflurane at the GABAA receptor alpha-3 subunit. Brain Res 2005;1032:30-5
40. Sonner JM, Werner DF, Elsen FP, Xing Y, Liao M, Harris RA, Harrison NL, Fanselow MS, Eger EI 2nd, Homanics GE. Effect of isoflurane and other potent inhaled anesthetics on minimum alveolar concentration, learning, and the righting reflex in mice engineered to express alpha1 gamma-aminobutyric acid type A receptors unresponsive to isoflurane. Anesthesiology 2007;106: 107-13